Meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 26059 [2021-10014]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 90 / Wednesday, May 12, 2021 / Notices
Dated: May 5, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2021–09980 Filed 5–11–21; 8:45 am]
Department of Health and Human
Services, Room L616, Switzer Building,
330 C. St. SW, Washington, DC 20024.
Phone: 202–746–1512; Email: CARB@
hhs.gov.
BILLING CODE 4164–01–P
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
for the Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB). The meeting will be open
to the public via WebEx and
teleconference; a pre-registered public
comment session will be held during
the meeting. Pre-registration is required
for members of the public who wish to
attend the meeting via WebEx/
teleconference. Individuals who wish to
send in their written public comment
should send an email to CARB@hhs.gov.
Registration information is available on
the website https://www.hhs.gov/paccarb
and must be completed by June 25,
2021. Additional information about
registering for the meeting and
providing public comment can be
obtained at https://www.hhs.gov/paccarb
on the Meetings page.
DATES: The meeting is scheduled to be
held on June 29, 2021, from 10:00 a.m.
to 3:00 p.m. and June 30, 2021, from
10:00 a.m. to 3:00 p.m. ET (times are
tentative and subject to change). The
confirmed times and agenda items for
the meeting will be posted on the
website for the PACCARB at https://
www.hhs.gov/paccarb when this
information becomes available. Preregistration for attending the meeting is
strongly suggested and should be
completed no later than June 25, 2021.
ADDRESSES: Instructions regarding
attending this meeting virtually will be
posted one week prior to the meeting at:
https://www.hhs.gov/paccarb.
FOR FURTHER INFORMATION CONTACT:
Jomana Musmar, M.S., Ph.D.,
Designated Federal Officer, Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of
the Assistant Secretary for Health, U.S.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:58 May 11, 2021
Jkt 253001
The
Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB), established by Executive
Order 13676, is continued by Section
505 of Public Law 116–22, the
Pandemic and All-Hazards
Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and
duties of the Advisory Council are
governed by the provisions of the
Federal Advisory Committee Act
(FACA), Public Law 92–463, as
amended (5 U.S.C. App.), which sets
forth standards for the formation and
use of federal advisory committees.
The PACCARB shall advise and
provide information and
recommendations to the Secretary
regarding programs and policies
intended to reduce or combat antibioticresistant bacteria that may present a
public health threat and improve
capabilities to prevent, diagnose,
mitigate, or treat such resistance. The
PACCARB shall function solely for
advisory purposes.
Such advice, information, and
recommendations may be related to
improving: The effectiveness of
antibiotics; research and advanced
research on, and the development of,
improved and innovative methods for
combating or reducing antibiotic
resistance, including new treatments,
rapid point-of-care diagnostics,
alternatives to antibiotics, including
alternatives to animal antibiotics, and
antimicrobial stewardship activities;
surveillance of antibiotic-resistant
bacterial infections, including publicly
available and up-to-date information on
resistance to antibiotics; education for
health care providers and the public
with respect to up-to-date information
on antibiotic resistance and ways to
reduce or combat such resistance to
antibiotics related to humans and
animals; methods to prevent or reduce
the transmission of antibiotic-resistant
bacterial infections; including
stewardship programs; and coordination
with respect to international efforts in
order to inform and advance the United
States capabilities to combat antibiotic
resistance.
The June 29–30, 2021, public meeting
will be dedicated to the council’s
deliberation and vote on two reports to
transmit to the Secretary of Health and
Human Services, the first from the
Disparities in Antibiotics Access and
Use Working Group, and the second
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
26059
from the Working Group on
Antimicrobial Resistance (AMR) in
Inter-Professional Education. The
remainder of the two-day public
meeting will include an update on the
status of the antibiotic development
pipeline and an open council discussion
on provocative questions in AMR (no
recommendations will be made), in
addition to presentations from subject
matter experts on Operationalizing One
Health and the Environmental
Dimensions of AMR. The meeting
agenda will be posted on the PACCARB
website at https://www.hhs.gov/paccarb
when it has been finalized. All agenda
items are tentative and subject to
change.
Instructions regarding attending this
meeting virtually will be posted one
week prior to the meeting at: https://
www.hhs.gov/paccarb.
Members of the public will have the
opportunity to provide comments live
during the meeting via conference line
by pre-registering online at https://
www.hhs.gov/paccarb. There will be
two separate sessions available for
public comment: An Innovation
Spotlight will be held on June 29th
where companies and/or organizations
involved in combating antibiotic
resistance have an opportunity to
present their work to members of the
Advisory Council; and on June 30th,
where all members of the general public
are welcome to provide oral comment
during this separate session. Preregistration is required for participation
in these sessions with limited spots
available. Further information about
these two sessions can be found online
at https://www.hhs.gov/paccarb. Written
public comments can also be emailed to
CARB@hhs.gov by midnight June 25,
2021 and should be limited to no more
than one page. All public comments
received prior to June 25, 2021, will be
provided to Advisory Council members.
Dated: April 30, 2021.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant
Secretary for Health.
[FR Doc. 2021–10014 Filed 5–11–21; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\12MYN1.SGM
12MYN1
]]>Agencies
[Federal Register Volume 86, Number 90 (Wednesday, May 12, 2021)]
[Notices]
[Page 26059]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10014]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a meeting is scheduled to be held for the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The
meeting will be open to the public via WebEx and teleconference; a pre-
registered public comment session will be held during the meeting. Pre-
registration is required for members of the public who wish to attend
the meeting via WebEx/teleconference. Individuals who wish to send in
their written public comment should send an email to [email protected].
Registration information is available on the website https://www.hhs.gov/paccarb and must be completed by June 25, 2021. Additional
information about registering for the meeting and providing public
comment can be obtained at https://www.hhs.gov/paccarb on the Meetings
page.
DATES: The meeting is scheduled to be held on June 29, 2021, from 10:00
a.m. to 3:00 p.m. and June 30, 2021, from 10:00 a.m. to 3:00 p.m. ET
(times are tentative and subject to change). The confirmed times and
agenda items for the meeting will be posted on the website for the
PACCARB at https://www.hhs.gov/paccarb when this information becomes
available. Pre-registration for attending the meeting is strongly
suggested and should be completed no later than June 25, 2021.
ADDRESSES: Instructions regarding attending this meeting virtually will
be posted one week prior to the meeting at: https://www.hhs.gov/paccarb.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, Room L616, Switzer Building,
330 C. St. SW, Washington, DC 20024. Phone: 202-746-1512; Email:
[email protected].
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by Section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the Advisory Council
are governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. App.), which sets forth
standards for the formation and use of federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary regarding programs and policies
intended to reduce or combat antibiotic-resistant bacteria that may
present a public health threat and improve capabilities to prevent,
diagnose, mitigate, or treat such resistance. The PACCARB shall
function solely for advisory purposes.
Such advice, information, and recommendations may be related to
improving: The effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The June 29-30, 2021, public meeting will be dedicated to the
council's deliberation and vote on two reports to transmit to the
Secretary of Health and Human Services, the first from the Disparities
in Antibiotics Access and Use Working Group, and the second from the
Working Group on Antimicrobial Resistance (AMR) in Inter-Professional
Education. The remainder of the two-day public meeting will include an
update on the status of the antibiotic development pipeline and an open
council discussion on provocative questions in AMR (no recommendations
will be made), in addition to presentations from subject matter experts
on Operationalizing One Health and the Environmental Dimensions of AMR.
The meeting agenda will be posted on the PACCARB website at https://www.hhs.gov/paccarb when it has been finalized. All agenda items are
tentative and subject to change.
Instructions regarding attending this meeting virtually will be
posted one week prior to the meeting at: https://www.hhs.gov/paccarb.
Members of the public will have the opportunity to provide comments
live during the meeting via conference line by pre-registering online
at https://www.hhs.gov/paccarb. There will be two separate sessions
available for public comment: An Innovation Spotlight will be held on
June 29th where companies and/or organizations involved in combating
antibiotic resistance have an opportunity to present their work to
members of the Advisory Council; and on June 30th, where all members of
the general public are welcome to provide oral comment during this
separate session. Pre-registration is required for participation in
these sessions with limited spots available. Further information about
these two sessions can be found online at https://www.hhs.gov/paccarb.
Written public comments can also be emailed to [email protected] by midnight
June 25, 2021 and should be limited to no more than one page. All
public comments received prior to June 25, 2021, will be provided to
Advisory Council members.
Dated: April 30, 2021.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2021-10014 Filed 5-11-21; 8:45 am]
BILLING CODE 4150-44-P
